318 related articles for article (PubMed ID: 26321154)
1. HPV vaccines: their pathology-based discovery, benefits, and adverse effects.
Nicol AF; de Andrade CV; Russomano FB; Rodrigues LS; Oliveira NS; Provance DW; Nuovo GJ
Ann Diagn Pathol; 2015 Dec; 19(6):418-22. PubMed ID: 26321154
[TBL] [Abstract][Full Text] [Related]
2. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
[TBL] [Abstract][Full Text] [Related]
3. Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection.
Brisson M; Van de Velde N; De Wals P; Boily MC
CMAJ; 2007 Aug; 177(5):464-8. PubMed ID: 17709404
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
5. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
Drolet M; Bénard É; Pérez N; Brisson M;
Lancet; 2019 Aug; 394(10197):497-509. PubMed ID: 31255301
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.
Rob F; Tachezy R; Pichlík T; Rob L; Kružicová Z; Hamšíková E; Šmahelová J; Hercogová J
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723194
[TBL] [Abstract][Full Text] [Related]
7. [Diseases caused by human papilloma viruses].
Zollner U; Schwarz TF
Dtsch Med Wochenschr; 2011 May; 136(20):1067-72. PubMed ID: 21560109
[TBL] [Abstract][Full Text] [Related]
8. Population impact of HPV vaccines: summary of early evidence.
Hariri S; Markowitz LE; Dunne EF; Unger ER
J Adolesc Health; 2013 Dec; 53(6):679-82. PubMed ID: 24263069
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus: clinical manifestations and prevention.
Juckett G; Hartman-Adams H
Am Fam Physician; 2010 Nov; 82(10):1209-13. PubMed ID: 21121531
[TBL] [Abstract][Full Text] [Related]
10. Currently approved prophylactic HPV vaccines.
Harper DM
Expert Rev Vaccines; 2009 Dec; 8(12):1663-79. PubMed ID: 19943762
[TBL] [Abstract][Full Text] [Related]
11. New viral vaccines for dermatologic disease.
Urman CO; Gottlieb AB
J Am Acad Dermatol; 2008 Mar; 58(3):361-70. PubMed ID: 18280332
[TBL] [Abstract][Full Text] [Related]
12. [AN HPV-ASSOCIATED DISEASES AND CERVICAL CANCER AND PROPHYLACTIC HUMAN PAPILLOMAVIRUS (HPV) VACCINES].
Malinova M
Akush Ginekol (Sofiia); 2015; 54 Suppl 1():25-31. PubMed ID: 26137767
[TBL] [Abstract][Full Text] [Related]
13. [Continue to use the bivalent HPV vaccine; bivalent vaccine more effective than expected].
Postma MJ; Wilschut JC
Ned Tijdschr Geneeskd; 2020 Jan; 164():. PubMed ID: 32073795
[TBL] [Abstract][Full Text] [Related]
14. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
; Dillner J; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen OE; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Joura EA; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Maansson R; Lu S; Vuocolo S; Hesley TM; Barr E; Haupt R
BMJ; 2010 Jul; 341():c3493. PubMed ID: 20647284
[TBL] [Abstract][Full Text] [Related]
15. Impact of HPV vaccination: health gains in the Italian female population.
Marcellusi A
Popul Health Metr; 2017 Sep; 15(1):36. PubMed ID: 28962572
[TBL] [Abstract][Full Text] [Related]
16. Trends in Genital Warts in the Era of Human Papillomavirus Vaccination.
Calo WA; Brewer NT
Sex Transm Dis; 2015 Dec; 42(12):669-70. PubMed ID: 26560967
[No Abstract] [Full Text] [Related]
17. [HPV vaccination with quadrivalent or nonavalent vaccine: an opportunity to eliminate genital warts as well].
van Bergen JEAM
Ned Tijdschr Geneeskd; 2020 Jan; 164():. PubMed ID: 32073799
[TBL] [Abstract][Full Text] [Related]
18. Primary prophylactic human papillomavirus vaccination programs: future perspective on global impact.
Brotherton JM; Gertig DM
Expert Rev Anti Infect Ther; 2011 Aug; 9(8):627-39. PubMed ID: 21819329
[TBL] [Abstract][Full Text] [Related]
19. An update on barriers to adolescent human papillomavirus vaccination in the USA.
Berenson AB
Expert Rev Vaccines; 2015; 14(10):1377-84. PubMed ID: 26292763
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy.
Brotherton JM; Kaldor JM; Garland SM
Sex Health; 2010 Sep; 7(3):310-9. PubMed ID: 20719220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
